ACM
CORT icon

Aquatic Capital Management’s Corcept Therapeutics CORT Stock Holding History

Aquatic Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,503
Closed -$141K – 1337
2026
Q1 		$141K Buy
3,503
+3,469
+10,203% +$130K ﹤0.01% 1049
2025
Q4 		$1.18K Sell
34
-12,524
-100% -$984K ﹤0.01% 1357
2025
Q3 		$1.04M Sell
12,558
-42,900
-77% -$3.1M 0.02% 660
2025
Q2 		$4.07M Buy
55,458
+11,440
+26% +$829K 0.08% 287
2025
Q1 		$5.03M Buy
44,018
+9,484
+27% +$577K 0.13% 211
2024
Q4 		$1.74M Buy
34,534
+17,634
+104% +$924K 0.05% 407
2024
Q3 		$782K Buy
16,900
+15,700
+1,308% +$558K 0.02% 549
2024
Q2 		$39K Sell
1,200
-6,000
-83% -$164K ﹤0.01% 1044
2024
Q1 		$181K Buy
7,200
+5,600
+350% +$132K 0.01% 786
2023
Q4 		$52K Buy
+1,600
New +$43.9K ﹤0.01% 1112
2023
Q3 		– Sell
-8,800
Closed -$196K – 1307
2023
Q2 		$196K Buy
+8,800
New +$203K 0.01% 674
2023
Q1 		– Sell
-36,000
Closed -$731K – 1335
2022
Q4 		$731K Buy
+36,000
New +$902K 0.05% 404
2022
Q2 		– Sell
-400
Closed -$9K – 1252
2022
Q1 		$9K Buy
+400
New +$8.51K 0.01% 682

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's CORT Position: Q2 2026 in Review

Aquatic Capital Management sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 3,503 shares — an estimated $141K sold.

Aquatic Capital Management first reported a position in CORT in Q1 2022 and held it in 13 quarters. The position peaked at $5.03M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Aquatic Capital Management reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 3,503 Corcept Therapeutics shares in Q2 2026, an estimated $141K.
  • Aquatic Capital Management first reported a position in Corcept Therapeutics in Q1 2022 and held it in 13 quarters.
  • Aquatic Capital Management's Corcept Therapeutics position peaked at $5.03M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.